In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women

1984 ◽  
Vol 149 (5) ◽  
pp. 477-480 ◽  
Author(s):  
H.Robert Harrison ◽  
Rosella M. Riggin ◽  
E.Russell Alexander ◽  
Louis Weinstein
Keyword(s):  
Chlamydia Trachomatis ◽  
Pregnant Women ◽  
Ureaplasma Urealyticum ◽  
Mycoplasma Hominis ◽  
Vitro Activity ◽  
In Vitro Activity

scholarly journals In Vitro Activity of Trovafloxacin Compared to Those of Five Antimicrobials against Mycoplasmas IncludingMycoplasma hominis and Ureaplasma urealyticumFluoroquinolone-Resistant Isolates That Have Been Genetically Characterized

2000 ◽  
Vol 44 (9) ◽  
pp. 2557-2560 ◽  
Author(s):  
C. M. Bebear ◽  
H. Renaudin ◽  
A. Charron ◽  
D. Gruson ◽  
M. Lefrancois ◽  
...  
Keyword(s):  
Ureaplasma Urealyticum ◽  
Mycoplasma Hominis ◽  
The Other ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Resistant Species

ABSTRACT The in vitro activity of trovafloxacin against 125 strains ofMycoplasma species and Ureaplasma urealyticum, including fluoroquinolone-susceptible and fluoroquinolone-resistant species, was compared to those of other fluoroquinolones, doxycycline, and erythromycin. The MIC at which 90% of isolates are inhibited for all fluoroquinolone-susceptible strains was 0.25 μg/ml. Whatever the associated mutations, trovafloxacin exhibited greater activity than the other fluoroquinolones tested against fluoroquinolone-resistantMycoplasma hominis and U. urealyticum isolates.

scholarly journals Activity of Cathelicidin Peptides against Chlamydia spp

2005 ◽  
Vol 49 (3) ◽  
pp. 1201-1202 ◽  
Author(s):  
Manuela Donati ◽  
Korinne Di Leo ◽  
Monica Benincasa ◽  
Francesca Cavrini ◽  
Silvia Accardo ◽  
...  
Keyword(s):  
Chlamydia Trachomatis ◽  
Vitro Activity ◽  
In Vitro Activity ◽  
Active Peptide

ABSTRACT The in vitro activity of six cathelicidin peptides against 25 strains of Chlamydia was investigated. SMAP-29 proved to be the most active peptide, reducing the inclusion numbers of all 10 strains of Chlamydia trachomatis tested by ≥50% at 10 μg/ml. This peptide was also active against C. pneumoniae and C. felis.

scholarly journals In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

2004 ◽  
Vol 48 (5) ◽  
pp. 1885-1886 ◽  
Author(s):  
S. A. Kohlhoff ◽  
P. M. Roblin ◽  
T. Reznik ◽  
S. Hawser ◽  
K. Islam ◽  
...  
Keyword(s):  
Chlamydia Trachomatis ◽  
Dihydrofolate Reductase ◽  
Reductase Inhibitor ◽  
Chlamydia Pneumoniae ◽  
Vitro Activity ◽  
Minimal Bactericidal Concentration ◽  
In Vitro Activity

ABSTRACT The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentration at which 90% of isolates were inhibited (MIC90 and MBC90) were 0.5 μg/ml, compared to an azithromycin MIC90 and MBC90 of 0.125 μg/ml and levofloxacin MIC90s and MBC90s of 1 μg/ml for C. trachomatis and 0.5 μg/ml for C. pneumoniae.

In vitro Activity of Nonoxynol-9 on McCoy Cells Infected with Chlamydia trachomatis

1987 ◽  
Vol 14 (3) ◽  
pp. 165-173 ◽  
Author(s):  
STEPHEN T. KNIGHT ◽  
SARA H. LEE ◽  
CAROLYN H. DAVIS ◽  
DAVlD R. MOORMAN ◽  
RICHARD L. HODINKA ◽  
...  
Keyword(s):  
Chlamydia Trachomatis ◽  
Vitro Activity ◽  
In Vitro Activity
Sign in / Sign up

Export Citation Format

Share Document